Second-generation antipsychotics: a therapeutic downturn?

被引:3
作者
Lewis, Shon [1 ]
机构
[1] Univ Manchester, Manchester, Lancs, England
关键词
Antipsychotic drugs; clinical trials; meta-analysis; schizophrenia; RANDOMIZED CONTROLLED-TRIAL; CHRONIC-SCHIZOPHRENIA; COST-EFFECTIVENESS; DRUGS; CLOZAPINE; OLANZAPINE;
D O I
10.1017/S0033291709990882
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:1603 / 1606
页数:4
相关论文
共 11 条
[1]   Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy [J].
Davies, L. M. ;
Lewis, S. ;
Jones, P. B. ;
Barnes, T. R. E. ;
Gaughran, F. ;
Hayhurst, K. ;
Markwick, A. ;
Lloyd, H. .
BRITISH JOURNAL OF PSYCHIATRY, 2007, 191 :14-22
[2]   Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis [J].
Geddes, J ;
Freemantle, N ;
Harrison, P ;
Bebbington, P .
BRITISH MEDICAL JOURNAL, 2000, 321 (7273) :1371-1376
[3]   Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia - Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) [J].
Jones, Peter B. ;
Barnes, Thomas R. E. ;
Davies, Linda ;
Dunn, Graham ;
Lloyd, Helen ;
Hayhurst, Karen P. ;
Murray, Robin M. ;
Markwick, Alison ;
Lewis, Shon W. .
ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (10) :1079-U6
[4]   Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder:: an open randomised clinical trial [J].
Kahn, Rene S. ;
Fleischhacker, W. Wolfgang ;
Boter, Han ;
Davidson, Michael ;
Vergouwe, Yvonne ;
Keet, Ireneus P. M. ;
Gheorghe, Mihai D. ;
Rybakowski, Janusz K. ;
Galderisi, Silvana ;
Libiger, Jan ;
Hummer, Martina ;
Dollfus, Sonia ;
Lopez-Ibor, Juan J. ;
Hranov, Luchezar G. ;
Gaebel, Wolfgang ;
Peuskens, Joseph ;
Lindefors, Nils ;
Riecher-Roessler, Anita ;
Grobbee, Diederick E. .
LANCET, 2008, 371 (9618) :1085-1097
[5]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
[6]   Second-generation antipsychotics for schizophrenia: can we resolve the conflict? [J].
Leucht, S. ;
Kissling, W. ;
Davis, J. M. .
PSYCHOLOGICAL MEDICINE, 2009, 39 (10) :1591-1602
[7]   Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia [J].
Lewis, Shon W. ;
Barnes, Thomas R. E. ;
Davies, Linda ;
Murray, Robin M. ;
Dunn, Graham ;
Hayhurst, Karen P. ;
Markwick, Alison ;
Lloyd, Helen ;
Jones, Peter B. .
SCHIZOPHRENIA BULLETIN, 2006, 32 (04) :715-723
[8]   Effectiveness of antipsychotic drugs in patients with chronic schizophrenia [J].
Lieberman, JA ;
Stroup, TS ;
McEvoy, JP ;
Swartz, MS ;
Rosenheck, RA ;
Perkins, DO ;
Keefe, RSE ;
Davis, SM ;
Davis, CE ;
Lebowitz, BD ;
Severe, J ;
Hsiao, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) :1209-1223
[9]   Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment [J].
McEvoy, JP ;
Lieberman, JA ;
Stroup, TS ;
Davis, SM ;
Meltzer, HY ;
Rosenheck, RA ;
Swartz, MS ;
Perkins, DO ;
Keefe, RSE ;
Davis, CE ;
Severe, J ;
Hsiao, JK .
AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (04) :600-610
[10]   Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia - A randomized controlled trial [J].
Rosenheck, R ;
Perlick, D ;
Bingham, S ;
Liu-Mares, W ;
Collins, J ;
Warren, S ;
Leslie, D ;
Allan, E ;
Campbell, EC ;
Caroff, S ;
Corwin, J ;
Davis, L ;
Douyon, R ;
Dunn, L ;
Evans, D ;
Frecska, E ;
Grabowski, J ;
Graeber, D ;
Herz, L ;
Kwon, K ;
Lawson, W ;
Mena, F ;
Sheikh, J ;
Smelson, D ;
Smith-Gamble, V .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (20) :2693-2702